Stay updated with breaking news from Rxponder trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Over the past 10 years, data from studies including the TAILORx and RxPONDER studies have reshaped treatment standards for patients with hormone receptor–positive, HER2-negative breast cancer. ....